Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cronos Group | CRON | Nov 26, 2024 | 2.09 | -1.88 |
Cross Country Healthcare | CCRN | Nov 26, 2024 | 10.66 | -1.93 |
Cross Timbers Royalty Royalty Trust | CRT | Nov 26, 2024 | 10.85 | +0.65 |
CrossAmerica Partners LP Unit | CAPL | Nov 26, 2024 | 20.26 | -0.83 |
CrossFirst Bankshares | CFB | Nov 26, 2024 | 17.63 | -1.78 |
CrowdStrike A | CRWD | Nov 26, 2024 | 364.30 | +0.17 |
Crown Castle | CCI | Nov 26, 2024 | 106.30 | +0.21 |
Crown Crafts | CRWS | Nov 26, 2024 | 4.60 | +0.66 |
Crown ElectroKinetics | CRKN | Nov 26, 2024 | 0.31 | -27.19 |
Crown Holdings | CCK | Nov 26, 2024 | 92.22 | -0.43 |
Crown LNG | CGBS | Nov 26, 2024 | 0.32 | -8.97 |
Cryo-Cell International | CCEL | Nov 26, 2024 | 9.00 | +1.47 |
CryoPort | CYRX | Nov 26, 2024 | 7.18 | +7.97 |
CS Disco | LAW | Nov 26, 2024 | 5.80 | -1.86 |
CSG Systems International | CSGS | Nov 26, 2024 | 54.82 | -0.72 |
CSP | CSPI | Nov 26, 2024 | 16.65 | -9.95 |
CSW Industrials | CSWI | Nov 26, 2024 | 423.58 | -1.95 |
CSX | CSX | Nov 26, 2024 | 36.69 | +0.19 |
CTO Realty Growth | CTO | Nov 26, 2024 | 19.99 | +0.65 |
CTO Realty Growth A Pref | CTO-A | Nov 26, 2024 | 23.52 | -0.89 |
CTS | CTS | Nov 26, 2024 | 54.46 | -1.82 |
CubeSmart | CUBE | Nov 26, 2024 | 49.92 | +0.12 |
Cue Biopharma | CUE | Nov 26, 2024 | 1.09 | +2.83 |
Cullen Frost Bankers B Pref | CFR-B | Nov 26, 2024 | 19.61 | -0.73 |
Cullen/Frost Bankers | CFR | Nov 26, 2024 | 142.91 | -0.70 |
Cullinan Therapeutics | CGEM | Nov 26, 2024 | 12.77 | +1.83 |
Cullman Bancorp | CULL | Nov 26, 2024 | 9.71 | 0.00 |
Culp | CULP | Nov 26, 2024 | 5.19 | 0.00 |
Cumberland Pharmaceuticals | CPIX | Nov 26, 2024 | 1.11 | +4.72 |
Cummins | CMI | Nov 26, 2024 | 377.39 | +0.56 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.